<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="case-report" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Med.</journal-id>
<journal-title>Frontiers in Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Med.</abbrev-journal-title>
<issn pub-type="epub">2296-858X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmed.2024.1483027</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Medicine</subject>
<subj-group>
<subject>Case Report</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Case report: Detection of non-O1/non-O139 <italic>Vibrio cholerae</italic> in a patient with hepatic space-occupying lesions using metagenomic next-generation sequencing</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Zhang</surname> <given-names>Wei</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref rid="fn00001" ref-type="author-notes"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1956616/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Xiao</surname> <given-names>Li</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref rid="fn00001" ref-type="author-notes"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2294532/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Shan</surname> <given-names>Xingxing</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Dai</surname> <given-names>Bing</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Tang</surname> <given-names>Chunyan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Xian</surname> <given-names>Jianchun</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2296349/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Yu</surname> <given-names>Yan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Changsha KingMed Diagnostics Group Co., Ltd.</institution>, <addr-line>Changsha, Hunan</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Infection and Hepatology, Taizhou People's Hospital Affiliated to Nanjing Medical University</institution>, <addr-line>Taizhou</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Nanjing KingMed Diagnostics Group Co., Ltd.</institution>, <addr-line>Nanjing, Jiangsu</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0001">
<p>Edited by: Shisan (Bob) Bao, The University of Sydney, Australia</p>
</fn>
<fn fn-type="edited-by" id="fn0002">
<p>Reviewed by: Susanne Fleischmann, Free University of Berlin, Germany</p>
<p>Silas Onyango Awuor, Jaramogi Oginga Odinga Teaching and Referral Hospital, Kenya</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Yan Yu, <email>hn-yuyan@kingmed.com.cn</email></corresp>
<fn id="fn00001" fn-type="equal">
<p><sup>&#x2020;</sup>These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>19</day>
<month>11</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>11</volume>
<elocation-id>1483027</elocation-id>
<history>
<date date-type="received">
<day>19</day>
<month>08</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>10</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2024 Zhang, Xiao, Shan, Dai, Tang, Xian and Yu.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Zhang, Xiao, Shan, Dai, Tang, Xian and Yu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec id="sec1">
<title>Introduction/background</title>
<p><italic>Vibrio cholerae</italic> is the causative agent of the human intestinal infectious disease cholera, which includes a variety of serogroups. However, there have been very few cases of hepatic space-occupying lesions associated with this infection. Currently, there are various methods for detecting this pathogen, including metagenomic sequencing, which enables quicker and more accurate identification. In this study, metagenomic sequencing is employed to accurately identify non-O1/O139 <italic>Vibrio cholerae</italic> infections by analyzing the genetic material present in clinical samples.</p>
</sec>
<sec id="sec2">
<title>Presentation of case</title>
<p>A 75-year-old man presented with diarrhea and fever after consuming crabs. The initial treatment improved the diarrhea, but a liver abscess developed later. Magnetic resonance imaging (MRI) of the liver revealed a hepatic space-occupying lesion. Upon further investigation, a Gram-negative, rod-shaped bacterium was cultured from the patient&#x2019;s liver puncture fluid, and <italic>Vibrio cholerae</italic> was detected in the same fluid using metagenomic next-generation sequencing (mNGS). The pathogen was confirmed to be non-O1/non-O139 <italic>Vibrio cholerae</italic> (<italic>NOVC</italic>) using polymerase chain reaction (PCR). Following treatment with piperacillin/tazobactam sodium and moxifloxacin, the patient&#x2019;s body temperature returned to normal, the liver abscess improved significantly, and he was subsequently discharged from the hospital.</p>
</sec>
<sec id="sec3">
<title>Discussion</title>
<p>This case study describes an elderly male patient with a hepatic space-occupying lesion. Multiple cultures of specimens failed to identify the underlying cause; however, advanced techniques such as mNGS and PCR confirmed an <italic>NOVC</italic> infection. This indicates that mNGS can serve as a valuable tool in diagnosing cases of unexplained liver infections.</p>
</sec>
<sec id="sec4">
<title>Conclusion</title>
<p>The use of mNGS is significant for detecting and clinically diagnosing infectious pathogens in patients with unexplained space-occupying lesions.</p>
</sec>
</abstract>
<kwd-group>
<kwd>non-O1/non-O139 <italic>Vibrio cholerae</italic></kwd>
<kwd>hepatic space-occupying lesions</kwd>
<kwd>culture</kwd>
<kwd>metagenomic next-generation sequencing</kwd>
<kwd>polymerase chain reaction</kwd>
</kwd-group>
<counts>
<fig-count count="4"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="30"/>
<page-count count="6"/>
<word-count count="3661"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Infectious Diseases: Pathogenesis and Therapy</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec5">
<label>1</label>
<title>Introduction</title>
<p><italic>Vibrio cholerae</italic> is a Gram-negative bacteria, belonging to the genus <italic>Vibrio</italic>. It is an aerobic, water-borne pathogen. Currently, there are more than 200 <italic>Vibrio cholerae</italic> serogroups (<xref ref-type="bibr" rid="ref1">1</xref>). Among these, O1 and O139 isolates typically produce the cholera toxin (<xref ref-type="bibr" rid="ref2">2</xref>). Infection after consuming water or food contaminated with <italic>Vibrio cholerae</italic> can lead to cholera, a severe intestinal infectious disease characterized by severe diarrhea and vomiting. If not treated in time, the mortality rate can reach up to 70%.</p>
<p>The non-O1/non-O139 <italic>Vibrio cholerae</italic> (<italic>NOVC</italic>) isolates cannot produce toxins and, therefore, cannot cause cholera. However, they can cause bacteremia and invasive extraintestinal diseases (<xref ref-type="bibr" rid="ref3">3</xref>, <xref ref-type="bibr" rid="ref4">4</xref>). The most common clinical manifestations of <italic>NOVC</italic> infection include gastroenteritis, but they can also cause septicemia (<xref ref-type="bibr" rid="ref5">5</xref>), chronic otitis media (<xref ref-type="bibr" rid="ref6">6</xref>), oral infections (<xref ref-type="bibr" rid="ref7">7</xref>), necrotizing fasciitis (<xref ref-type="bibr" rid="ref8">8</xref>), endophthalmitis (<xref ref-type="bibr" rid="ref9">9</xref>), meningitis (<xref ref-type="bibr" rid="ref10">10</xref>), and other invasive infections. There have been only a few reports of this bacterium causing hepatic space-occupying lesions.</p>
<p>Metagenomic next-generation sequencing (mNGS) is a culture-free and bias-free pathogen detection technology based on next-generation sequencing technology. It can simultaneously detect a variety of pathogens including bacteria, fungi, viruses, and parasites using high-throughput sequencing of DNA and/or RNA directly extracted from clinical samples, followed by data comparison and bioinformatics analysis (<xref ref-type="bibr" rid="ref11">11</xref>, <xref ref-type="bibr" rid="ref12">12</xref>). Currently, it is gradually being transferred from research to clinical laboratories and used to identify pathogens in different infected parts of the body, such as respiratory infections, central nervous system infections, bloodstream infections, gastrointestinal infections, ocular infections, urinary tract infections, and hepatobiliary infections (<xref ref-type="bibr" rid="ref11">11</xref>&#x2013;<xref ref-type="bibr" rid="ref13">13</xref>). Studies have shown that mNGS detection can be used to diagnose unknown infections in body fluids. This study tested 182 body fluids from 160 patients with&#x2009;acute illness using two sequencing platforms for mNGS. The results were compared to other diagnostic methods, such as culture, 16S bacterial PCR, and/or 28S internal donated ribosomal gene spacer (28S ITS) functional PCR. The sensitivity and specificity of the test for bacteria and fungi were over 75%, as determined by Illumina sequencing (<xref ref-type="bibr" rid="ref14">14</xref>).</p>
</sec>
<sec id="sec6">
<label>2</label>
<title>Case report</title>
<p>A 75-year-old man was admitted with fever and diarrhea. Routine examination and inquiry revealed that the patient had a clear history of seafood consumption before the onset of the disease. The patient consumed crabs that had been stored in the refrigerator for 8&#x2009;days before developing symptoms of diarrhea and fever. Levofloxacin was used for anti-infection treatment in a local hospital, and the symptoms of diarrhea were relieved, but liver abscesses appeared. Later, the patient was transferred to our hospital for treatment. After undergoing an MRI examination of the liver at our hospital, a hepatic space-occupying lesion was identified.</p>
<p>On admission, his vital signs were as follows: white blood cell (WBC) count was 10.03&#x2009;&#x00D7;&#x2009;10^9/L, with 69.3% neutrophils, 21.5% lymphocytes, and 7.0% monocytes. The concentration of procalcitonin (PCT) was 0.120&#x2009;ng/mL, and the serum C-reactive protein concentration was 81.76&#x2009;mg/L. Additionally, the patient had a mild fever upon admission (<xref ref-type="fig" rid="fig1">Figure 1a</xref>). Furthermore, the liver MRI scan revealed a hepatic space-occupying lesion (<xref ref-type="fig" rid="fig1">Figure 1c</xref>). No white blood cells were found in the smear of the liver puncture fluid.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Nursing record sheet and liver MRI examination. (a) At the time of admission, a low fever was observed. (b) A follow-up after treatment indicated that the admission examination reveals a normal body temperature. (c) The initial liver MRI examination shows hepatic space-occupying lesions; (d) After treatment, a follow-up liver MRI examination shows improvement in liver abscess.</p>
</caption>
<graphic xlink:href="fmed-11-1483027-g001.tif"/>
</fig>
<p>Based on the MRI results, a liver abscess was suspected 1&#x2009;week after admission, and a 21-day regimen of piperacillin/tazobactam sodium (4.5&#x2009;g every 8&#x2009;h) and moxifloxacin hydrochloride (0.4&#x2009;g once daily) was started to treat the infection. Although there was a reduction in the size of the lesion, it did not completely disappear. Then, the patient&#x2019;s condition was reassessed. Blood, feces, and liver puncture fluid samples were collected. After disinfecting the skin, approximately 5&#x2009;mL of blood was collected through venipuncture. For the stool sample, a swab was used to collect an amount equivalent to the size of a peanut (approximately 5&#x2009;g).</p>
<p>In addition, under the guidance of CT or ultrasound, an 8-ml sample of the liver abscess fluid was aspirated through a puncture. All of the specimens were preserved and cultured at Nanjing KingMed Diagnostics (a third-party laboratory). Blood culture results were negative. <italic>Escherichia coli</italic> and <italic>Enterococcus faecium</italic> were identified in stool culture. The liver puncture fluid was inoculated onto a Columbia blood plate. After 24&#x2009;h of incubation, a small amount of curved, Gram-negative, rod-shaped bacterium was observed growing on the blood agar under the microscope (<xref ref-type="fig" rid="fig2">Figure 2a</xref>).</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Culture results show a Gram-negative curved rod-shaped bacterium. (&#x00D7;1,000). (a) Gram-negative curved rod-shaped bacterium in blood agar. (b) Gram-negative curved rod-shaped bacterium in BacT/ALERT&#x00AE; FA culture bottles. (c) Gram-negative curved rod-shaped bacterium in a blood plate, isolated from BacT/ALERT&#x00AE; FA culture bottles.</p>
</caption>
<graphic xlink:href="fmed-11-1483027-g002.tif"/>
</fig>
<p>The liver puncture fluid was also inoculated into a BacT/ALERT&#x00AE; FA culture bottle. After 120&#x2009;h of incubation, the culture medium was taken from the BacT/ALERT&#x00AE; FA culture bottle, and Gram-negative rod-shaped bacteria with slight swelling and curvature were observed under a microscope (<xref ref-type="fig" rid="fig2">Figure 2b</xref>). The colony morphology suggested the presence of a rod-shaped bacterium. Subsequently, the liquid in the bottle was transferred to Columbia blood plates for further cultivation. After 24&#x2009;h, curved Gram-negative rod-shaped bacteria were observed under the microscope (<xref ref-type="fig" rid="fig2">Figure 2c</xref>). Unfortunately, pathogen identification was not possible.</p>
<p>To further confirm the pathogen of infection, mNGS detection was conducted. Subsequently, the liver puncture fluid was sent for mNGS testing (KingMed Diagnostics, Changsha, China). The experimental process of mNGS includes the extraction of nucleic acids (DNA and/or RNA), fragmentation, library preparation, and sequencing. By analyzing and processing the sequencing data, the microorganisms found in the specimen can be identified and studied. The mNGS results reported a <italic>V. cholerae</italic> infection. DNA mNGS detected 108 sequences that can be mapped to <italic>V. cholerae</italic>, with a coverage of 0.19% (<xref ref-type="fig" rid="fig3">Figure 3a</xref>). RNA mNGS detected 14 sequences that can be mapped to <italic>V. cholerae</italic>, with a coverage of 0.02% (<xref ref-type="fig" rid="fig3">Figure 3b</xref>). To verify the serotype of <italic>V. cholerae</italic>, five genes were amplified by PCR in the sliver puncture fluid, including <italic>ompw</italic>, <italic>ctxa</italic>, <italic>tcpa</italic>, <italic>rfb</italic>, and <italic>hlya</italic> (<xref ref-type="table" rid="tab1">Table 1</xref>). However, <italic>ctxa</italic>, <italic>tcpa</italic>, <italic>rfb</italic>, and <italic>hlya</italic> did not amplify any specific fragments (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Finally, the confirmation of the <italic>NOVC</italic> strain was achieved by mNGS and PCR at Changsha KingMed Diagnostics (a third-party laboratory).</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>mNGS results of the liver puncture fluid. (a) The DNA mNGS results show that the coverage of <italic>Vibrio cholerae</italic> was 0.19%. (b) The RNA mNGS results show that the coverage of <italic>Vibrio cholerae</italic> was 0.02%.</p>
</caption>
<graphic xlink:href="fmed-11-1483027-g003.tif"/>
</fig>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Primer for <italic>Vibrio cholerae</italic> verification.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Primer name</th>
<th align="left" valign="top">Sequence (5&#x2032; to 3&#x2032;)</th>
<th align="center" valign="top">Base number</th>
<th align="left" valign="top">Gene description</th>
<th align="center" valign="top">References</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle"><italic>VCompw</italic>-F</td>
<td align="left" valign="middle">AGTCCTCGCTGCTACGCCATT</td>
<td align="center" valign="middle">21</td>
<td align="left" valign="middle" rowspan="2">A gene of an outer<break/>membrane protein</td>
<td align="center" valign="middle" rowspan="2">(<xref ref-type="bibr" rid="ref27">27</xref>, <xref ref-type="bibr" rid="ref28">28</xref>)</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>VCompw</italic>-R</td>
<td align="left" valign="middle">CTGCTTTGTAGGTTGCCGTTGTTTC</td>
<td align="center" valign="middle">25</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>VCctxa</italic>-F</td>
<td align="left" valign="middle">GACGGGATTTGTTAGGCACGATGAT</td>
<td align="center" valign="middle">25</td>
<td align="left" valign="middle" rowspan="2">Cholera toxin gene</td>
<td align="center" valign="middle" rowspan="2">(<xref ref-type="bibr" rid="ref29">29</xref>)</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>VCctxa</italic>-R</td>
<td align="left" valign="middle">GCATGATGAATCCACGGCTCTTCC</td>
<td align="center" valign="middle">24</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>VCtcpa</italic>-F</td>
<td align="left" valign="middle">TGGCTCAGCGTGCGATTGATTC</td>
<td align="center" valign="middle">22</td>
<td align="left" valign="middle" rowspan="2">Toxin coregulated pilus A</td>
<td align="center" valign="middle" rowspan="2">(<xref ref-type="bibr" rid="ref28">28</xref>)</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>VCtcpa</italic>-R</td>
<td align="left" valign="middle">AGCACAAAGGTTCTGAACATGGGTA</td>
<td align="center" valign="middle">25</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>VCrfb</italic>-F</td>
<td align="left" valign="middle">ACTGACGGATGGTGAAGTGATTGC</td>
<td align="center" valign="middle">24</td>
<td align="left" valign="middle" rowspan="2">Antigen-specific gene of <italic>Vibrio cholerae</italic> O1 and O139</td>
<td align="center" valign="middle" rowspan="2">(<xref ref-type="bibr" rid="ref30">30</xref>)</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>VCrfb</italic>-R</td>
<td align="left" valign="middle">CTCTGTTGCTACTGCCGATTCTTGT</td>
<td align="center" valign="middle">25</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>VChlya</italic>-F</td>
<td align="left" valign="middle">TTGTTAGAGGCACCACGCACTG</td>
<td align="center" valign="middle">22</td>
<td align="left" valign="middle" rowspan="2"><italic>Vibrio cholerae-specific</italic> hemolysin genes</td>
<td align="center" valign="middle" rowspan="2">(<xref ref-type="bibr" rid="ref29">29</xref>)</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>VChlya</italic>-R</td>
<td align="left" valign="middle">TTCGGACCATCTCCACTGACTTCA</td>
<td align="center" valign="middle">24</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p>Results of the gene PCR. Except for <italic>ompw</italic>, other O1/O139 <italic>Vibrio cholerae</italic> toxicity-related genes are not amplified by PCR. (<italic>ompw-positive</italic>, <italic>ctxa-negative</italic>, <italic>tcpa-negative</italic>, <italic>rfb-negative</italic>, and <italic>hlya-negative</italic>).</p>
</caption>
<graphic xlink:href="fmed-11-1483027-g004.tif"/>
</fig>
<p>This patient had a clear history of seafood consumption before the onset of the disease. Subsequently, it was confirmed to be <italic>NOVC</italic> through mNGS and PCR testing. Based on experience and recommendations from the ninth edition of &#x201C;<italic>Infectious Diseases</italic>&#x201D; by the People&#x2019;s Health Publishing House, quinolone drugs are preferred for treating cholera infection. Therefore, the use of a moxifloxacin antibiotic was continued for treatment. After 40&#x2009;days of treatment, the patient&#x2019;s temperature tended to be stable, and he was discharged without fever. After 7&#x2009;months of follow-up, the body temperature was normal (<xref ref-type="fig" rid="fig1">Figure 1b</xref>). After anti-infection treatment, the hepatic space-occupying lesions improved (<xref ref-type="fig" rid="fig1">Figure 1d</xref>).</p>
</sec>
<sec sec-type="discussion" id="sec7">
<label>3</label>
<title>Discussion</title>
<p>In this report, a 75-year-old man with <italic>NOVC</italic> infection was described. He suffered from hepatic space-occupying lesions and had consumed crabs that had been refrigerated for a long time. To the best of our knowledge, this is the first case of <italic>NOVC</italic> infection identified using mNGS in a patient with hepatic space-occupying lesions.</p>
<p><italic>Vibrio cholerae</italic> is widely distributed in aquatic environments. Humans can contract an infection by consuming contaminated food, especially seafood and fish (<xref ref-type="bibr" rid="ref15">15</xref>). Over the last 20&#x2009;years, diseases caused by <italic>NOVC</italic> have increased steadily worldwide (<xref ref-type="bibr" rid="ref15">15</xref>).</p>
<p>Studies have shown that infections caused by <italic>NOVC</italic> are more common in patients with underlying diseases or low immunity. Cirrhosis is the most common risk factor in mainland China, followed by malignancy, hematological malignancies, and diabetes (<xref ref-type="bibr" rid="ref5">5</xref>, <xref ref-type="bibr" rid="ref16">16</xref>). <italic>NOVC</italic> bacteremia (<xref ref-type="bibr" rid="ref17">17</xref>) and septicemia (<xref ref-type="bibr" rid="ref18">18</xref>) have been found in patients with liver cirrhosis. However, <italic>NOVC</italic> sepsis was also reported in a patient who had no underlying disease (<xref ref-type="bibr" rid="ref19">19</xref>). As stated in the case, the patient had liver space-occupying symptoms, but the early symptoms were insufficient to support a diagnosis of <italic>NOVC</italic> infection.</p>
<p>The patient&#x2019;s WBC count was slightly higher, whereas the cell proportion and PCT were normal. In addition, C-reactive protein (CRP) levels increased significantly, and the patient&#x2019;s body temperature increased, indicating an infection. After culturing samples from the blood, feces, and liver puncture fluid, no bacteria were detected. <italic>Escherichia coli</italic> and <italic>Enterococcus faecium</italic> were cultured from feces. Curved Gram-negative, rod-shaped bacteria were found in the liver puncture fluid, and the bacterial morphology was consistent with that of <italic>V. cholerae</italic>. However, the culture method is time-consuming and has limitations (<xref ref-type="bibr" rid="ref20">20</xref>). Due to limited conditions, it was not possible to cultivate a single colony and conduct drug sensitivity tests. Afterward, <italic>Vibrio cholerae</italic> was detected using mNGS, and the toxicity-related genes of O1/O139 <italic>Vibrio cholerae</italic> were not amplified by PCR, confirming that the bacterium is <italic>NOVC</italic>. Following treatment based on clinical experience and mNGS results, the patient&#x2019;s physical signs improved. <italic>NOVC</italic> was not found in blood and fecal cultures, demonstrating the importance of selecting the appropriate sample type. Due to the rarity of the <italic>NOVC</italic> infection, its diagnosis may be challenging. Agglutination with O1 antiserum can be used to exclude other types of <italic>Vibrio cholerae</italic> infection, which is typically performed in clinical laboratories and can be difficult for initial diagnosis (<xref ref-type="bibr" rid="ref21">21</xref>).</p>
<p>However, mNGS is increasingly used to detect pathogens directly from clinical specimens (<xref ref-type="bibr" rid="ref20">20</xref>). At present, mNGS is used to detect and diagnose secondary infection in patients with severe <italic>Legionella pneumonia</italic> after treatment (<xref ref-type="bibr" rid="ref22">22</xref>). In addition, research has shown that mNGS has advantages in terms of speed and sensitivity for detecting pathogens in mixed lung infections (<xref ref-type="bibr" rid="ref23">23</xref>). Now, mNGS can be used to identify pathogens in infectious CNS diseases, providing certain advantages over traditional detection methods (<xref ref-type="bibr" rid="ref24">24</xref>). Rare pathogens can also be identified using mNGS, such as <italic>Chlamydia psittaci</italic>, <italic>Orientia tsutsugamushi</italic>, and others (<xref ref-type="bibr" rid="ref25">25</xref>, <xref ref-type="bibr" rid="ref26">26</xref>). In this case, the liver puncture fluid was detected using mNGS technology, which confirmed the presence of <italic>V. cholerae</italic>. In general, this shows that the detection of unidentified infected body fluids through mNGS is of significant importance for clinical diagnosis.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="sec8">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author/s.</p>
</sec>
<sec sec-type="ethics-statement" id="sec9">
<title>Ethics statement</title>
<p>Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.</p>
</sec>
<sec sec-type="author-contributions" id="sec10">
<title>Author contributions</title>
<p>WZ: Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. LX: Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. XS: Writing &#x2013; review &#x0026; editing. BD: Writing &#x2013; review &#x0026; editing. CT: Writing &#x2013; review &#x0026; editing. JX: Writing &#x2013; review &#x0026; editing. YY: Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec sec-type="funding-information" id="sec11">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.</p>
</sec>
<ack>
<p>We thank Hu Ge, Yuan Cao, Changlin Liu, Qiuran Lu, and Han Zhou from Changsha KingMed Diagnostics for the technical support of this study.</p>
</ack>
<sec sec-type="COI-statement" id="sec12">
<title>Conflict of interest</title>
<p>WZ, BD, CT, and YY were employed by Changsha KingMed Diagnostics Group Co., Ltd. XS was employed by Nanjing KingMed Diagnostics Group Co., Ltd.</p>
<p>The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="sec13">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1">
<label>1.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clemens</surname> <given-names>JD</given-names></name> <name><surname>Nair</surname> <given-names>GB</given-names></name> <name><surname>Ahmed</surname> <given-names>T</given-names></name> <name><surname>Qadri</surname> <given-names>F</given-names></name> <name><surname>Holmgren</surname> <given-names>J</given-names></name></person-group>. <source>Cholera Lancet</source>. (<year>2017</year>) <volume>390</volume>:<fpage>1539</fpage>&#x2013;<lpage>49</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(17)30559-7</pub-id></citation>
</ref>
<ref id="ref2">
<label>2.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bhandari</surname> <given-names>M</given-names></name> <name><surname>Jennison</surname> <given-names>AV</given-names></name> <name><surname>Rathnayake</surname> <given-names>IU</given-names></name> <name><surname>Huygens</surname> <given-names>F</given-names></name></person-group>. <article-title>Evolution, distribution and genetics of atypical <italic>Vibrio cholerae</italic> - a review</article-title>. <source>Infect Genet Evol</source>. (<year>2021</year>) <volume>89</volume>:<fpage>104726</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.meegid.2021.104726</pub-id>, PMID: <pub-id pub-id-type="pmid">33482361</pub-id></citation>
</ref>
<ref id="ref3">
<label>3.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ko</surname> <given-names>WC</given-names></name> <name><surname>Chuang</surname> <given-names>YC</given-names></name> <name><surname>Huang</surname> <given-names>GC</given-names></name> <name><surname>Hsu</surname> <given-names>SY</given-names></name></person-group>. <article-title>Infections due to non-O1 <italic>Vibrio cholerae</italic> in southern Taiwan: predominance in cirrhotic patients</article-title>. <source>Clin Infect Dis</source>. (<year>1998</year>) <volume>27</volume>:<fpage>774</fpage>&#x2013;<lpage>80</lpage>. doi: <pub-id pub-id-type="doi">10.1086/514947</pub-id>, PMID: <pub-id pub-id-type="pmid">9798033</pub-id></citation>
</ref>
<ref id="ref4">
<label>4.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>X</given-names></name> <name><surname>Lu</surname> <given-names>Y</given-names></name> <name><surname>Qian</surname> <given-names>H</given-names></name> <name><surname>Liu</surname> <given-names>G</given-names></name> <name><surname>Mei</surname> <given-names>Y</given-names></name> <name><surname>Jin</surname> <given-names>F</given-names></name> <etal/></person-group>. <article-title>Non-O1, non-O139 <italic>Vibrio cholerae</italic> (<italic>NOVC</italic>) bacteremia: case report and literature review, 2015-2019</article-title>. <source>Infect Drug Resist</source>. (<year>2020</year>) <volume>13</volume>:<fpage>1009</fpage>&#x2013;<lpage>16</lpage>. doi: <pub-id pub-id-type="doi">10.2147/IDR.S245806</pub-id>, PMID: <pub-id pub-id-type="pmid">32308442</pub-id></citation>
</ref>
<ref id="ref5">
<label>5.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zmeter</surname> <given-names>C</given-names></name> <name><surname>Tabaja</surname> <given-names>H</given-names></name> <name><surname>Sharara</surname> <given-names>AI</given-names></name> <name><surname>Kanj</surname> <given-names>SS</given-names></name></person-group>. <article-title>Non-O1, non-O139 <italic>Vibrio cholerae</italic> septicemia at a tertiary care center in Beirut, Lebanon; a case report and review</article-title>. <source>J Infect Public Health</source>. (<year>2018</year>) <volume>11</volume>:<fpage>601</fpage>&#x2013;<lpage>4</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jiph.2018.01.001</pub-id></citation>
</ref>
<ref id="ref6">
<label>6.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Van Bonn</surname> <given-names>SM</given-names></name> <name><surname>Schraven</surname> <given-names>SP</given-names></name> <name><surname>Schuldt</surname> <given-names>T</given-names></name> <name><surname>Heimesaat</surname> <given-names>MM</given-names></name> <name><surname>Mlynski</surname> <given-names>R</given-names></name> <name><surname>Warnke</surname> <given-names>PC</given-names></name></person-group>. <article-title>Chronic otitis media following infection by non-O1/non-O139 <italic>Vibrio cholerae</italic>: a case report and review of the literature</article-title>. <source>Eur J Microbiol Immunol</source>. (<year>2020</year>) <volume>10</volume>:<fpage>186</fpage>&#x2013;<lpage>91</lpage>. doi: <pub-id pub-id-type="doi">10.1556/1886.2020.00013</pub-id></citation>
</ref>
<ref id="ref7">
<label>7.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname> <given-names>H</given-names></name> <name><surname>Wu</surname> <given-names>Y</given-names></name> <name><surname>Liu</surname> <given-names>C</given-names></name> <name><surname>Guo</surname> <given-names>J</given-names></name> <name><surname>Ma</surname> <given-names>J</given-names></name> <name><surname>Li</surname> <given-names>X</given-names></name> <etal/></person-group>. <article-title>Oral infection caused by non-O1/non-O139 <italic>Vibrio cholerae</italic> in a patient with esophageal Cancer undergoing Esophagectomy and Chemoradiotherapy: a case report</article-title>. <source>Infect Drug Resist</source>. (<year>2020</year>) <volume>13</volume>:<fpage>3923</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.2147/IDR.S274077</pub-id>, PMID: <pub-id pub-id-type="pmid">33173317</pub-id></citation>
</ref>
<ref id="ref8">
<label>8.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsuruta</surname> <given-names>K</given-names></name> <name><surname>Ueyama</surname> <given-names>T</given-names></name> <name><surname>Watanabe</surname> <given-names>T</given-names></name> <name><surname>Nakano</surname> <given-names>K</given-names></name> <name><surname>Uno</surname> <given-names>K</given-names></name> <name><surname>Fukushima</surname> <given-names>H</given-names></name></person-group>. <article-title>Intensive care management of a patient with necrotizing fasciitis due to non-O1/O139 <italic>Vibrio cholerae</italic> after traveling to Taiwan: a case report</article-title>. <source>BMC Infect Dis</source>. (<year>2020</year>) <volume>20</volume>:<fpage>618</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12879-020-05343-6</pub-id>, PMID: <pub-id pub-id-type="pmid">32831039</pub-id></citation>
</ref>
<ref id="ref9">
<label>9.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>CC</given-names></name> <name><surname>Lee</surname> <given-names>BJ</given-names></name> <name><surname>Yang</surname> <given-names>SS</given-names></name> <name><surname>Lin</surname> <given-names>YH</given-names></name> <name><surname>Lee</surname> <given-names>YL</given-names></name></person-group>. <article-title>A case of non-O1 and non-O139 <italic>Vibrio cholerae</italic> septicemia with endophthalmitis in a cirrhotic patient</article-title>. <source>Jpn J Infect Dis</source>. (<year>2008</year>) <volume>61</volume>:<fpage>475</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.7883/yoken.JJID.2008.475</pub-id></citation>
</ref>
<ref id="ref10">
<label>10.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname> <given-names>Y</given-names></name> <name><surname>Wang</surname> <given-names>Y</given-names></name> <name><surname>Bi</surname> <given-names>Z</given-names></name> <name><surname>Sun</surname> <given-names>B</given-names></name> <name><surname>Jin</surname> <given-names>Y</given-names></name> <name><surname>Bai</surname> <given-names>Y</given-names></name> <etal/></person-group>. <article-title>A case of non-O1/non-O139 <italic>Vibrio cholerae</italic> septicemia and meningitis in a neonate</article-title>. <source>Int J Infect Dis</source>. (<year>2015</year>) <volume>35</volume>:<fpage>117</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijid.2015.05.004</pub-id></citation>
</ref>
<ref id="ref11">
<label>11.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname> <given-names>CY</given-names></name> <name><surname>Miller</surname> <given-names>SA</given-names></name></person-group>. <article-title>Clinical metagenomics</article-title>. <source>Nat Rev Genet</source>. (<year>2019</year>) <volume>20</volume>:<fpage>341</fpage>&#x2013;<lpage>55</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41576-019-0113-7</pub-id>, PMID: <pub-id pub-id-type="pmid">30918369</pub-id></citation>
</ref>
<ref id="ref12">
<label>12.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname> <given-names>W</given-names></name> <name><surname>Miller</surname> <given-names>S</given-names></name> <name><surname>Chiu</surname> <given-names>CY</given-names></name></person-group>. <article-title>Clinical metagenomic next-generation sequencing for pathogen detection</article-title>. <source>Annu Rev Pathol</source>. (<year>2019</year>) <volume>14</volume>:<fpage>319</fpage>&#x2013;<lpage>38</lpage>. doi: <pub-id pub-id-type="doi">10.1146/annurev-pathmechdis-012418-012751</pub-id>, PMID: <pub-id pub-id-type="pmid">30355154</pub-id></citation>
</ref>
<ref id="ref13">
<label>13.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>D</given-names></name> <name><surname>Li</surname> <given-names>Z</given-names></name> <name><surname>Li</surname> <given-names>R</given-names></name> <name><surname>Tan</surname> <given-names>P</given-names></name> <name><surname>Zhang</surname> <given-names>R</given-names></name> <name><surname>Li</surname> <given-names>J</given-names></name></person-group>. <article-title>mNGS in clinical microbiology laboratories: on the road to maturity</article-title>. <source>Crit Rev Microbiol</source>. (<year>2019</year>) <volume>45</volume>:<fpage>668</fpage>&#x2013;<lpage>85</lpage>. doi: <pub-id pub-id-type="doi">10.1080/1040841X.2019.1681933</pub-id>, PMID: <pub-id pub-id-type="pmid">31691607</pub-id></citation>
</ref>
<ref id="ref14">
<label>14.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname> <given-names>W</given-names></name> <name><surname>Deng</surname> <given-names>X</given-names></name> <name><surname>Lee</surname> <given-names>M</given-names></name> <name><surname>Sucu</surname> <given-names>YD</given-names></name> <name><surname>Arevalo</surname> <given-names>S</given-names></name> <name><surname>Stryke</surname> <given-names>D</given-names></name> <etal/></person-group>. <article-title>Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids</article-title>. <source>Nat Med</source>. (<year>2021</year>) <volume>27</volume>:<fpage>115</fpage>&#x2013;<lpage>24</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41591-020-1105-z</pub-id>, PMID: <pub-id pub-id-type="pmid">33169017</pub-id></citation>
</ref>
<ref id="ref15">
<label>15.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>&#x0160;pa&#x010D;kov&#x00E1;</surname> <given-names>M</given-names></name> <name><surname>Ko&#x0161;&#x0165;&#x00E1;lov&#x00E1;</surname> <given-names>J</given-names></name> <name><surname>Fabi&#x00E1;nov&#x00E1;</surname> <given-names>K</given-names></name></person-group>. <article-title>Non-O1/non-O139 vibrios - occurrence not only in Europe in recent years</article-title>. <source>Epidemiol Mikrobiol Imunol</source>. (<year>2021</year>) <volume>70</volume>:<fpage>131</fpage>&#x2013;<lpage>8</lpage>.</citation>
</ref>
<ref id="ref16">
<label>16.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>X</given-names></name> <name><surname>Wu</surname> <given-names>Y</given-names></name> <name><surname>Sun</surname> <given-names>X</given-names></name> <name><surname>Ma</surname> <given-names>J</given-names></name> <name><surname>Li</surname> <given-names>X</given-names></name> <name><surname>Liu</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>Non-O1/non-O139 <italic>Vibrio cholerae</italic> bacteraemia in mainland China from 2005 to 2019: clinical, epidemiological and genetic characteristics</article-title>. <source>Epidemiol Infect</source>. (<year>2020</year>) <volume>148</volume>:<fpage>e186</fpage><comment>. Published 2020 Jul 8</comment>. doi: <pub-id pub-id-type="doi">10.1017/S0950268820001545</pub-id>, PMID: <pub-id pub-id-type="pmid">32635946</pub-id></citation>
</ref>
<ref id="ref17">
<label>17.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gallardo-Cartagena</surname> <given-names>JA</given-names></name> <name><surname>Chiappe-Gonzalez</surname> <given-names>AJ</given-names></name> <name><surname>Astocondor-Salazar</surname> <given-names>LM</given-names></name> <name><surname>Salazar-Mesones</surname> <given-names>BN</given-names></name> <name><surname>Narcizo Susanibar</surname> <given-names>JA</given-names></name> <name><surname>Cucho-Espinoza</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>Bacteremia por <italic>Vibrio cholerae</italic> NO-O1/NO-O139 en un paciente cirr&#x00F3;tico. Primer reporte de caso en el Per&#x00FA; y revisi&#x00F3;n de la literatura [<italic>Vibrio cholerae</italic> NO-O1/NO-O139 bacteremia in a cirrhotic patient. First case report in Peru and literatura review]</article-title>. <source>Revista Gastroenterologia Peru</source>. (<year>2018</year>) <volume>38</volume>:<fpage>301</fpage>&#x2013;<lpage>5</lpage>. PMID: <pub-id pub-id-type="pmid">30540737</pub-id></citation>
</ref>
<ref id="ref18">
<label>18.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname> <given-names>T</given-names></name> <name><surname>Kitai</surname> <given-names>S</given-names></name> <name><surname>Hayaishi</surname> <given-names>S</given-names></name> <name><surname>Kudo</surname> <given-names>M</given-names></name></person-group>. <article-title>Septicemia due to <italic>Vibrio cholerae</italic> serogroup non-O1/non-O139 strain in a cirrhotic patient</article-title>. <source>Clin J Gastroenterol</source>. (<year>2012</year>) <volume>5</volume>:<fpage>383</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12328-012-0332-3</pub-id>, PMID: <pub-id pub-id-type="pmid">26181318</pub-id></citation>
</ref>
<ref id="ref19">
<label>19.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname> <given-names>S</given-names></name> <name><surname>Kim</surname> <given-names>Y</given-names></name> <name><surname>Jung</surname> <given-names>H</given-names></name> <name><surname>Chang</surname> <given-names>HH</given-names></name> <name><surname>Kim</surname> <given-names>SJ</given-names></name> <name><surname>Park</surname> <given-names>HK</given-names></name> <etal/></person-group>. <article-title>A fatal case of bacteremia caused by <italic>Vibrio cholerae</italic> non-O1/O139</article-title>. <source>Infect Chemother</source>. (<year>2021</year>) <volume>53</volume>:<fpage>384</fpage>&#x2013;<lpage>90</lpage>. doi: <pub-id pub-id-type="doi">10.3947/ic.2020.0301</pub-id>, PMID: <pub-id pub-id-type="pmid">32869555</pub-id></citation>
</ref>
<ref id="ref20">
<label>20.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Filkins</surname> <given-names>LM</given-names></name> <name><surname>Bryson</surname> <given-names>AL</given-names></name> <name><surname>Miller</surname> <given-names>SA</given-names></name> <name><surname>Mitchell</surname> <given-names>SL</given-names></name></person-group>. <article-title>Navigating clinical utilization of direct-from-specimen metagenomic pathogen detection: clinical applications, limitations, and testing recommendations</article-title>. <source>Clin Chem</source>. (<year>2020</year>) <volume>66</volume>:<fpage>1381</fpage>&#x2013;<lpage>95</lpage>. doi: <pub-id pub-id-type="doi">10.1093/clinchem/hvaa183</pub-id>, PMID: <pub-id pub-id-type="pmid">33141913</pub-id></citation>
</ref>
<ref id="ref21">
<label>21.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname> <given-names>S</given-names></name> <name><surname>Kumar</surname> <given-names>A</given-names></name> <name><surname>Meparambu</surname> <given-names>D</given-names></name> <name><surname>Thomas</surname> <given-names>S</given-names></name> <name><surname>Harichandran</surname> <given-names>D</given-names></name> <name><surname>Karim</surname> <given-names>S</given-names></name></person-group>. <article-title>Fatal non-O1, non-O139 <italic>Vibrio cholerae</italic> septicaemia in a patient with chronic liver disease</article-title>. <source>J Med Microbiol</source>. (<year>2013</year>) <volume>62</volume>:<fpage>917</fpage>&#x2013;<lpage>21</lpage>. doi: <pub-id pub-id-type="doi">10.1099/jmm.0.049296-0</pub-id></citation>
</ref>
<ref id="ref22">
<label>22.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yue</surname> <given-names>R</given-names></name> <name><surname>Wu</surname> <given-names>X</given-names></name> <name><surname>Li</surname> <given-names>T</given-names></name> <name><surname>Chang</surname> <given-names>L</given-names></name> <name><surname>Huang</surname> <given-names>X</given-names></name> <name><surname>Pan</surname> <given-names>L</given-names></name></person-group>. <article-title>Early detection of <italic>Legionella pneumophila</italic> and <italic>aspergillus</italic> by mNGS in a critically ill patient with <italic>Legionella</italic> pneumonia after extracorporeal membrane oxygenation treatment: case report and literature review</article-title>. <source>Front Med</source>. (<year>2021</year>) <volume>8</volume>:<fpage>686512</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmed.2021.686512</pub-id>, PMID: <pub-id pub-id-type="pmid">34277662</pub-id></citation>
</ref>
<ref id="ref23">
<label>23.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>J</given-names></name> <name><surname>Han</surname> <given-names>Y</given-names></name> <name><surname>Feng</surname> <given-names>J</given-names></name></person-group>. <article-title>Metagenomic next-generation sequencing for mixed pulmonary infection diagnosis</article-title>. <source>BMC Pulm Med</source>. (<year>2019</year>) <volume>19</volume>:<fpage>252</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12890-019-1022-4</pub-id></citation>
</ref>
<ref id="ref24">
<label>24.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xing</surname> <given-names>XW</given-names></name> <name><surname>Zhang</surname> <given-names>JT</given-names></name> <name><surname>Ma</surname> <given-names>YB</given-names></name> <name><surname>He</surname> <given-names>MW</given-names></name> <name><surname>Yao</surname> <given-names>GE</given-names></name> <name><surname>Wang</surname> <given-names>W</given-names></name> <etal/></person-group>. <article-title>Metagenomic next-generation sequencing for diagnosis of infectious encephalitis and meningitis: a large, prospective case series of 213 patients</article-title>. <source>Front Cell Infect Microbiol</source>. (<year>2020</year>) <volume>10</volume>:<fpage>88</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2020.00088</pub-id>, PMID: <pub-id pub-id-type="pmid">32211343</pub-id></citation>
</ref>
<ref id="ref25">
<label>25.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname> <given-names>L</given-names></name> <name><surname>Liu</surname> <given-names>W</given-names></name> <name><surname>Ru</surname> <given-names>M</given-names></name> <name><surname>Lin</surname> <given-names>J</given-names></name> <name><surname>Yu</surname> <given-names>G</given-names></name> <name><surname>Ye</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>The application of metagenomic next-generation sequencing in diagnosing <italic>Chlamydia psittaci</italic> pneumonia: a report of five cases</article-title>. <source>BMC Pulm Med</source>. (<year>2020</year>) <volume>20</volume>. <comment>Published 2020 Mar 17</comment>:<fpage>65</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12890-020-1098-x</pub-id>, PMID: <pub-id pub-id-type="pmid">32178660</pub-id></citation>
</ref>
<ref id="ref26">
<label>26.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>J</given-names></name> <name><surname>Chen</surname> <given-names>C</given-names></name> <name><surname>Zou</surname> <given-names>F</given-names></name> <name><surname>Liu</surname> <given-names>L</given-names></name> <name><surname>Wang</surname> <given-names>B</given-names></name> <name><surname>Kang</surname> <given-names>H</given-names></name> <etal/></person-group>. <article-title>Diagnosing scrub typhus without eschar: a case report using metagenomic next-generation sequencing (mNGS)</article-title>. <source>Annal Transl Med</source>. (<year>2021</year>) <volume>9</volume>:<fpage>1190</fpage>. doi: <pub-id pub-id-type="doi">10.21037/atm-21-3015</pub-id>, PMID: <pub-id pub-id-type="pmid">34430631</pub-id></citation>
</ref>
<ref id="ref27">
<label>27.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname> <given-names>X</given-names></name> <name><surname>Zhang</surname> <given-names>J</given-names></name> <name><surname>Li</surname> <given-names>T</given-names></name> <name><surname>Zhang</surname> <given-names>M</given-names></name> <name><surname>Li</surname> <given-names>J</given-names></name> <name><surname>Kan</surname> <given-names>B</given-names></name></person-group>. <article-title>The outer membrane protein OmpW enhanced <italic>V. cholerae</italic> growth in hypersaline conditions by transporting carnitine</article-title>. <source>Front Microbiol</source>. (<year>2018</year>) <volume>8</volume>:<fpage>2703</fpage>. <comment>Published 2018 Jan 22</comment>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2017.02703</pub-id>, PMID: <pub-id pub-id-type="pmid">29403450</pub-id></citation>
</ref>
<ref id="ref28">
<label>28.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zareitaher</surname> <given-names>T</given-names></name> <name><surname>Sadat Ahmadi</surname> <given-names>T</given-names></name> <name><surname>Gargari</surname> <given-names>LM</given-names></name></person-group>. <article-title>Immunogenic efficacy of DNA and protein-based vaccine from a chimeric gene consisting <italic>OmpW</italic>, <italic>TcpA</italic> and <italic>CtxB</italic>, of <italic>Vibrio cholerae</italic></article-title>. <source>Immunobiology</source>. (<year>2022</year>) <volume>227</volume>:<fpage>152190</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.imbio.2022.152190</pub-id>, PMID: <pub-id pub-id-type="pmid">35220071</pub-id></citation>
</ref>
<ref id="ref29">
<label>29.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meena</surname> <given-names>B</given-names></name> <name><surname>Anburajan</surname> <given-names>L</given-names></name> <name><surname>Sathish</surname> <given-names>T</given-names></name> <name><surname>Das</surname> <given-names>AK</given-names></name> <name><surname>Vinithkumar</surname> <given-names>NV</given-names></name> <name><surname>Kirubagaran</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Studies on diversity of Vibrio sp. and the prevalence of <italic>hapA</italic>, <italic>tcpI</italic>, <italic>st</italic>, <italic>rtxA&#x0026;C</italic>, <italic>acfB</italic>, <italic>hlyA</italic>, <italic>ctxA</italic>, <italic>ompU</italic> and <italic>toxR</italic> genes in environmental strains of <italic>Vibrio cholerae</italic> from Port Blair bays of south Andaman, India</article-title>. <source>Mar Pollut Bull</source>. (<year>2019</year>) <volume>144</volume>:<fpage>105</fpage>&#x2013;<lpage>16</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.marpolbul.2019.05.011</pub-id>, PMID: <pub-id pub-id-type="pmid">31179975</pub-id></citation>
</ref>
<ref id="ref30">
<label>30.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stroeher</surname> <given-names>UH</given-names></name> <name><surname>Jedani</surname> <given-names>KE</given-names></name> <name><surname>Dredge</surname> <given-names>BK</given-names></name> <name><surname>Morona</surname> <given-names>R</given-names></name> <name><surname>Brown</surname> <given-names>MH</given-names></name> <name><surname>Karageorgos</surname> <given-names>LE</given-names></name> <etal/></person-group>. <article-title>Genetic rearrangements in the rfb regions of <italic>Vibrio cholerae</italic> O1 and O139</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>1995</year>) <volume>92</volume>:<fpage>10374</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.92.22.10374</pub-id>, PMID: <pub-id pub-id-type="pmid">7479787</pub-id></citation>
</ref>
</ref-list>
</back>
</article>